Activated platelets retain and protect most of their factor XIII-A cargo from proteolytic activation and degradation
| dc.contributor.author | Sang, Yaqiu | |
| dc.contributor.author | Lee, Robert H | |
| dc.contributor.author | Luong, Annie | |
| dc.contributor.author | Katona, Éva | |
| dc.contributor.author | Whyte, Claire S | |
| dc.contributor.author | Smith, Nicholas L | |
| dc.contributor.author | Mast, Alan E | |
| dc.contributor.author | Flick, Matthew J | |
| dc.contributor.author | Mutch, Nicola J | |
| dc.contributor.author | Bergmeier, Wolfgang | |
| dc.contributor.author | Wolberg, Alisa S | |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.date.accessioned | 2024-10-11T13:34:01Z | |
| dc.date.available | 2024-10-11T13:34:01Z | |
| dc.date.issued | 2024-10-08 | |
| dc.description | The authors thank László Muszbek for the polyclonal anti-FXIII-Aantibody,Abigail R. Ballardfor technical support, Pablo Ariel for help with the immunofluorescence imaging and analysis, Marina Sokolsky for help with nanoparticle tracking analysis,and Nigel Mackman and Kadri Kangro for reading the manuscript.The Microscopy Services Laboratory, Department of Pathology and Laboratory Medicine, is supported in part by a Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer Center(P30 CA016086). | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 14 | |
| dc.format.extent | 3220706 | |
| dc.identifier | 292647193 | |
| dc.identifier | f46fb4fb-d6b8-44b6-86b1-6cd463593393 | |
| dc.identifier | 39116293 | |
| dc.identifier | 85206335879 | |
| dc.identifier.citation | Sang, Y, Lee, R H, Luong, A, Katona, É, Whyte, C S, Smith, N L, Mast, A E, Flick, M J, Mutch, N J, Bergmeier, W & Wolberg, A S 2024, 'Activated platelets retain and protect most of their factor XIII-A cargo from proteolytic activation and degradation', Blood Advances, vol. 8, no. 19, 2024012979, pp. 5072–5085. https://doi.org/10.1182/bloodadvances.2024012979 | en |
| dc.identifier.doi | 10.1182/bloodadvances.2024012979 | |
| dc.identifier.issn | 2473-9529 | |
| dc.identifier.other | ORCID: /0000-0001-8127-6102/work/166226933 | |
| dc.identifier.other | ORCID: /0000-0002-7452-0813/work/169538857 | |
| dc.identifier.uri | https://hdl.handle.net/2164/24380 | |
| dc.identifier.url | https://www.scopus.com/pages/publications/85206335879 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Blood Advances | en |
| dc.subject | Substantive link via an eligible employment contract | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Platelets and Thrombopoiesis | en |
| dc.subject | Thrombosis and Hemostasis | en |
| dc.subject | R Medicine (General) | en |
| dc.subject.lcc | R1 | en |
| dc.title | Activated platelets retain and protect most of their factor XIII-A cargo from proteolytic activation and degradation | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Sang_etal_BA_Activated_Platelets_Retain_VoR.pdf
- Size:
- 3.07 MB
- Format:
- Adobe Portable Document Format
